FGFR3 and AL amyloidosis: FGFR3 protein overexpression drives tumor progression in bladder cancer, lung cancer, multiple myeloma, and glioblastoma, whereas it prevents tumor progression in cutaneous squamous cell carcinoma 25, 26.